New York: Simon & Schuster
Cell metabolism, 30(1), 6777.e3
It is often considered by individuals exposed to everyday environmental stressors, those interested in supporting healthy aging, and people looking to maintain respiratory wellness
Clinical response must be monitored
20 mg in female arousal studies Subcutaneous injection: 0.75 mg, 1.25 mg, and 1.75 mg in Phase 2-3 female HSDD trials FDA-approved dose: 1.75 mg subcutaneously as needed, at least 45 minutes before sexual activity Important: These are doses from completed clinical trials
is a family physician currently based in the Department of Endocrinology, Tan Tock Seng Hospital (TTSH), where she is part of the TTSH Weight Management Service